Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. Additionally we are shipping Myosin Heavy Chain 7, Cardiac Muscle, beta Kits (20) and Myosin Heavy Chain 7, Cardiac Muscle, beta Proteins (4) and many more products for this protein.
Showing 10 out of 54 products:
Human Monoclonal MYH7 Primary Antibody for IHC (p), WB - ABIN1108367
Rizzo, Mazzeo, Biasiucci, Cingolani, Gigli: White electroluminescence from a microcontact-printing-deposited CdSe/ZnS colloidal quantum-dot monolayer. in Small (Weinheim an der Bergstrasse, Germany) 2008
Study shows lack of phenotypic differences between MYH7- and MYBPC3 (show MYBPC3 Antibodies)-associated hypertrophic cardiomyopathy when assessed by cardiac magnetic resonance imaging.
Two novel heterozygous proline substitutions located in exon 31 of MYH7 within its rod domain:c.4309G>C (p.Ala1437Pro) and c.4301G>C (p.Arg1434Pro) is causing skeletal myopathies.
MYBPC3 (show MYBPC3 Antibodies) and MYH7 were the most common mutated genes, accounting for 27% of the total Hypertrophic Cardiomyopathy patients and 83% of the putative mutations in the main sarcomeric genes.
MYH7 gene mutation is associated with Early-Onset Hypertrophic Cardiomyopathy.
family members who carried both the MYH7-A719H and MYOZ2 (show MYOZ2 Antibodies)-L169G mutations had more severe symptoms of hypertrophic cardiomyopathy, including sudden cardiac death, than those with only the MYH7 mutation
Chinese family with dual LQT1 (show KCNQ1 Antibodies) and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1 (show KCNQ1 Antibodies), MYH7, MYLK2 (show MYLK2 Antibodies), and TMEM70 (show TMM70 Antibodies) mutations.
A novel heterozygous mutation (MYH7, p.Asn885Thr), and a variant of uncertain significance (TNNT2 (show TNNT2 Antibodies), p.Arg296His) were identified in 2 patients with familial hypertrophic cardiomyopathy.
Multidimensional structure-function relationships in human beta-cardiac myosin from population-scale genetic variation.
BNP (show BNC2 Antibodies), but not mutations in MYH7 may have a role in sudden cardiac death in children with hypertrophic cardiomyopathy
5 out of 102 (4.9%) athletes carried mutations: a heterozygous MYH7 Glu935Lys mutation, a heterozygous MYBPC3 (show MYBPC3 Antibodies) Arg160Trp mutation and another heterozygous MYBPC3 (show MYBPC3 Antibodies) Thr1046Met mutation, all of which had been reported as HCM-associated mutations
Tm affects the conformation of actin so as to increase the area of hydrophobic interaction between actin and myosin molecules
Myosin regulatory light chain phosphorylation enhances cardiac beta-myosin in vitro motility under load.
Mutation analysis of MYH7 gene revealed an in-frame insertion within exon 30 of MYH7 which was perfectly associated with the disease phenotype and confirmed the dominant inheritance.
The promoter regions of the SERCA (show ATP2A3 Antibodies)-2A and beta-MHC genes, Atp2a2 (show ATP2A2 Antibodies) and Myh7, respectively in murine hearts after one or eight weeks of pressure overload induced by transverse aortic constriction, were evaluated.
Foxo1 (show FOXO1 Antibodies) has important roles in promoting diabetic cardiomyopathy and controls beta-MHC expression in the development of cardiac dysfunction.
Cooperative/allosteric effects on actomyosin crossbridge recruitment dynamics are increased by beta-MHC.
Reexpression of bMHC is associated at the bMHC promoter with increased H3ac but not H3K4me3.
Metabolic and myosin isoform gene expression switch in sepsis-induced myocardial depression is inducible nitric oxide synthase (show NOS2 Antibodies)-dependent.
residues situated within or close to the actin-binding interface of the myosin head influence actin binding and thereby modulate actin-activated ATPase (show DNAH8 Antibodies) activity
Simultaneous defects in MHC7 & TnI (show TNNI2 Antibodies) accelerate onset & progression of familial hypertrophic cardiomyopathy. Compared with single-mutant models, double-mutant mice develop severe disease & premature death, progressing directly to a dilated phenotype.
the functional consequences of the mutation are fundamentally changed depending upon the context of the cardiac MHC isoform.
Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy.
, chick atrial myosin heavy chain
, heavy polypeptide 7
, myosin heavy chain
, myosin, heavy polypeptide 7, cardiac muscle, beta
, masticatory myosin heavy chain 16
, beta-myosin heavy chain
, myopathy, distal 1
, myosin heavy chain (AA 1-96)
, myosin heavy chain 7
, myosin heavy chain slow isoform
, myosin heavy chain, cardiac muscle beta isoform
, rhabdomyosarcoma antigen MU-RMS-40.7A
, beta myosin heavy chain
, myosin heavy chain polypeptide 7 cardiac muscle fetal
, myosin heavy chain, cardiac muscle, fetal
, myosin heavy chain, polypeptide 7
, type slow/beta myosin heavy chain
, beta cardiac myosin heavy chain
, myosin 7
, myosin heavy chain slow type 1 (beta cardiac)
, cardiac myosin heavy chain beta